XNYS
COTY
Market cap1.90bUSD
Jul 09, Last price
2.13USD
1D
-0.47%
1Q
-1.84%
Jan 2017
-88.37%
IPO
-87.84%
Name
Coty Inc
Chart & Performance
P/E
—
P/S
0.32
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.81%
Rev. gr., 5y
4.55%
Revenues
5.89b
-3.68%
Net income
-368m
L
CFO
493m
-19.85%
Dividend
Feb 14, 20200.125 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Coty Inc., along with its affiliates, manufactures, markets, and distributes beauty products worldwide. The company offers a range of luxury fragrances, skincare, and color cosmetics, which are sold through high-end retail outlets such as perfumeries, department stores, online retailers, direct-to-consumer websites, and duty-free shops. Its prestige portfolio includes well-known names like Alexander McQueen, Burberry, Bottega Veneta, Calvin Klein, Cavalli, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Joop!, Kylie Jenner, Lacoste, Lancaster, Marc Jacobs, Miu Miu, Nikos, philosophy, Kim Kardashian West, and Tiffany & Co. Additionally, Coty provides mass-market color cosmetics, fragrances, skincare, and body care items. These products are primarily available at hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce platforms. This segment features brands such as Adidas, Beckham, Biocolor, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, Stetson, and 007 James Bond. The company also distributes its products through third-party partners to approximately 150 countries and territories. Established in 1904, Coty Inc. is headquartered in New York, New York, and operates as a subsidiary of Cottage Holdco B.V.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||